Related references
Note: Only part of the references are listed.Increased Placental sFLT1 (Soluble fms-Like Tyrosine Kinase Receptor-1) Drives the Antiangiogenic Profile of Maternal Serum Preceding Preeclampsia but Not Fetal Growth Restriction
Francesca Gaccioli et al.
HYPERTENSION (2023)
Clinical tools and biomarkers to predict preeclampsia
Teresa M. MacDonald et al.
EBIOMEDICINE (2022)
Primary Trophoblast Cultures: Characterization of HLA Profiles and Immune Cell Interactions
Michael Eikmans et al.
FRONTIERS IN IMMUNOLOGY (2022)
Revealing Molecular Mechanisms Supporting Trophoblast-Mediated Maternal Immune Tolerance
Michelle M. Williams et al.
ENDOCRINOLOGY (2022)
Macrophage migration inhibitory factor in human early pregnancy events and association with placental pathologies
Milica Jovanovic Krivokuca et al.
PLACENTA (2021)
Crosstalk Between Trophoblasts and Decidual Immune Cells: The Cornerstone of Maternal-Fetal Immunotolerance
Ling Xu et al.
FRONTIERS IN IMMUNOLOGY (2021)
HLA-G: An Important Mediator of Maternal-Fetal Immune-Tolerance
Baimei Zhuang et al.
FRONTIERS IN IMMUNOLOGY (2021)
The Vascular Endothelial Growth Factor Inhibitor Soluble FLT-1 Ameliorates Atopic Dermatitis in APOC1 Transgenic Mice
Cleo C. L. van Aanhold et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)
The immune system and microbiome in pregnancy
G. M. Fuhler
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2020)
Trophoblast lineage-specific differentiation and associated alterations in preeclampsia and fetal growth restriction
Omar Farah et al.
PLACENTA (2020)
Progress in deciphering trophoblast cell differentiation during human placentation
Zhenyu Xiao et al.
CURRENT OPINION IN CELL BIOLOGY (2020)
Decreased expression of ligands of placental immune checkpoint inhibitors in uncomplicated and preeclamptic oocyte donation pregnancies
L. J. van't Hof et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2020)
MIF inhibition enhances pulmonary angiogenesis and lung development in congenital diaphragmatic hernia
Shahana Perveen et al.
PEDIATRIC RESEARCH (2019)
Evolving complexity of MIF signaling
Stanislovas S. Jankauskas et al.
CELLULAR SIGNALLING (2019)
Rediscovering MIF: New Tricks for an Old Cytokine
James Harris et al.
TRENDS IN IMMUNOLOGY (2019)
Placental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsia
Ai-ris Yonekura Collier et al.
HYPERTENSION IN PREGNANCY (2019)
Maternal and umbilical cord blood level of macrophage migration inhibitory factor and insulin like growth factor in Sudanese women with preeclampsia
Selma Mahmoud et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2019)
Derivation of Human Trophoblast Stem Cells
Hiroaki Okae et al.
CELL STEM CELL (2018)
Role of the Macrophage Migration Inhibitory Factor (MIF) in the survival of first trimester human placenta under induced stress conditions
Francesca Ietta et al.
SCIENTIFIC REPORTS (2018)
Loss of placental growth factor ameliorates maternal hypertension and preeclampsia in mice
Jacqueline G. Parchem et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
PD-L1 Expression in Human Placentas and Gestational Trophoblastic Diseases
Emanuela Veras et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2017)
Resolution of inflammation pathways in preeclampsia-a narrative review
Luiza Oliveira Perucci et al.
IMMUNOLOGIC RESEARCH (2017)
The VEGF-A inhibitor sFLT-1 improves renal function by reducing endothelial activation and inflammation in a mouse model of type 1 diabetes
Pascal Bus et al.
DIABETOLOGIA (2017)
The role of high-mobility group box protein 1 in collagen antibody-induced arthritis is dependent on vascular endothelial growth factor
F. Biscetti et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
Suppressed Production of Soluble Fms-Like Tyrosine Kinase-1 Contributes to Myocardial Remodeling and Heart Failure
Ayako Seno et al.
HYPERTENSION (2016)
Interleukin-4 and granulocyte-macrophage colony-stimulating factor mediates the upregulation of soluble vascular endothelial growth factor receptor-1 in RAW264.7 cells-a process in which p38 mitogen-activated protein kinase signaling has an important role
Lin Xia et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2016)
Case of soluble fms-like tyrosine kinase 1 apheresis in severe pre-eclampsia developed at 15 weeks' gestation
Baku Nakakita et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2015)
Pharmacological inhibition of MIF interferes with trophoblast cell migration and invasiveness
M. Jovanovic Krivokuca et al.
PLACENTA (2015)
Does soluble fms-like tyrosine kinase-1 regulate placental invasion? Insight from the invasive placenta
Kerry McMahon et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2014)
Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications
Xiujun Fan et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
OP005. Preeclampsia is associated with the presence of transcriptionally active placental fragments in the maternal lung
Buurma Aletta et al.
Pregnancy Hypertension-An International Journal of Womens Cardiovascular Health (2013)
Pilot Study of Extracorporeal Removal of Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia
Ravi Thadhani et al.
CIRCULATION (2011)
The Effect of Immune Factors, Tumor Necrosis Factor-α, and Agonistic Autoantibodies to the Angiotensin II Type I Receptor on Soluble fms-Like Tyrosine-1 and Soluble Endoglin Production in Response to Hypertension During Pregnancy
Marc R. Parrish et al.
AMERICAN JOURNAL OF HYPERTENSION (2010)
Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis
Helia B. Schonthaler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Autoantibody from women with preeclampsia induces soluble fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling
Cissy Chenyi Zhou et al.
HYPERTENSION (2008)
Angiotensin II induces soluble fms-like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy
Cissy Chenyi Zhou et al.
CIRCULATION RESEARCH (2007)
Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1
Ori Nevo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2006)
Human decidual natural killer cells as a source and target of macrophage migration inhibitory factor
F Arcuri et al.
REPRODUCTION (2006)
Increased levels of macrophage migration inhibitory factor (MIF) in preeclampsia
T Todros et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2005)
Circulating angiogenic factors and the risk of preeclampsia
RJ Levine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
GM-CSF induces expression of soluble VEGF receptor-1 from human monocytes and inhibits angiogenesis in mice
TD Eubank et al.
IMMUNITY (2004)
Share Paper
